Your browser doesn't support javascript.
loading
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.
Veilleux, Olivier; Claveau, Jean-Sébastien; Alaoui, Habiba; Roy, Jean; Ahmad, Imran; Delisle, Jean-Sébastien; Kiss, Thomas; Bambace, Nadia M; Bernard, Léa; Cohen, Sandra; Sauvageau, Guy; Fleury, Isabelle; Mollica, Luigina; Roy, Denis-Claude; Serroukh, Yasmina; Lachance, Sylvie.
Affiliation
  • Veilleux O; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Claveau JS; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Alaoui H; Hematology division, CHU Mohammed VI, Oujda, Maroc.
  • Roy J; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Ahmad I; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Delisle JS; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Kiss T; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Bambace NM; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Bernard L; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Cohen S; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Sauvageau G; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Fleury I; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Mollica L; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Roy DC; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada.
  • Serroukh Y; Department of Hematology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Netherlands.
  • Lachance S; Hôpital Maisonneuve-Rosemont, Division of Hematology, Medical Oncology and Hematopoietic Cell Transplant Program, Université de Montréal, Montréal, Québec, Canada. Electronic address: silvy.lachance@umontreal.ca.
Transplant Cell Ther ; 28(3): 145-151, 2022 03.
Article in En | MEDLINE | ID: mdl-34954149
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Observational_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Transplant Cell Ther Year: 2022 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos